Literature DB >> 23767832

VEGF, PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic patients.

Selda Demircan Sezer1, Mert Küçük, Firuzan Kaçar Döger, Hasan Yüksel, Ali Rıza Odabaşi, Münevver Kaynak Türkmen, Bilin Çetinkaya Cakmak, Imran Kurt Ömürlü, Murat Gökhan Kinaş.   

Abstract

PURPOSE: The aim of this study was to compare the VEGF, PIGF, and HIF-1α levels in the placentas of early- and late-onset pre-eclamptic patients, which are thought to be important in pathophysiology of pre-eclampsia. MATERIAL AND
METHOD: Pre-eclamptic early-onset (n = 22) and late-onset (n = 24) pregnant women and a control group of healthy pregnant women (n = 22) were recruited for this case-control study. A semi-quantitative immunohistochemical analysis of VEGF, PIGF and HIF-1α was performed in cross-sections of the placentas of the subjects, after which results were compared.
RESULTS: Levels of VEGF and PIGF in the placentas of pre-eclamptic patients were found to be lower than the levels in the placentas of healthy pregnant women (p < 0.001 and p = 0.025, respectively), whereas the levels of HIF-1α were found significantly higher (p < 0.001). No difference was observed in terms of VEGF, PIGF and HIF-1α in a comparison of the early- and late-onset pre-eclampsia groups (p > 0.05).
CONCLUSION: The results of the study indicated that there is no relationship between the time of onset of pre-eclampsia and the placental changes that occur in these factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23767832     DOI: 10.3109/09513590.2013.801437

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

2.  Adenosine A2A receptor regulates expression of vascular endothelial growth factor in feto-placental endothelium from normal and late-onset pre-eclamptic pregnancies.

Authors:  Jesenia Acurio; Kurt Herlitz; Felipe Troncoso; Claudio Aguayo; Patricio Bertoglia; Carlos Escudero
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

3.  First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lucie Hympanova; Jindrich Doucha; Ladislav Krofta
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

4.  Kisspeptin treatment improves fetal-placental development and blocks placental oxidative damage caused by maternal hypothyroidism in an experimental rat model.

Authors:  Bianca Reis Santos; Jeane Martinha Dos Anjos Cordeiro; Luciano Cardoso Santos; Erikles Macedo Barbosa; Letícia Dias Mendonça; Emilly Oliveira Santos; Isabella Oliveira de Macedo; Mário Sergio Lima de Lavor; Raphael Escorsim Szawka; Rogeria Serakides; Juneo Freitas Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

Review 5.  From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.

Authors:  Sonya Frazier; Martin W McBride; Helen Mulvana; Delyth Graham
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

Review 6.  PlGF Immunological Impact during Pregnancy.

Authors:  Loredana Albonici; Monica Benvenuto; Chiara Focaccetti; Loredana Cifaldi; Martino Tony Miele; Federica Limana; Vittorio Manzari; Roberto Bei
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

7.  Bioinformatics-based identification of miRNA-, lncRNA-, and mRNA-associated ceRNA networks and potential biomarkers for preeclampsia.

Authors:  Ruoan Jiang; Ting Wang; Feifei Zhou; Yingsha Yao; Jing He; Dong Xu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.